BioSpace News Archive

AVEO Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of 21,739,131 shares of common stock and short-term warrants to purchase up to 21,739,131 shares of common stock at a price to the public of $1.15 per share and accompanying warrant.

Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today published research in Nature describing the first high-resolution structure of full-length human ATP-citrate lyase (ACLY), a building block of human metabolism

The World Trade Centers Association (WTCA) — a network of more than 300 highly-connected, mutually supportive businesses and organizations — will host its 50th annual General Assembly (GA), drawing upwards of 500 representatives from Member World Trade Centers, foreign trade delegations and local Mexico companies

A new NSTA Press book supports elementary students as they learn to use argument to construct, support, and evaluate scientific claims. Argument-Driven Inquiry in Third-Grade Science: Three-Dimensional Investigations emphasizes “figuring things out” instead of “learning about things.”

Perficient, Inc. (NASDAQ: PRFT) (“Perficient”), the leading digital transformation consulting firm serving Global 2000® and other large enterprise customers throughout North America, today announced it has successfully implemented Oracle’s Siebel Clinical Trial Management System (CTMS) in the Oracle Cloud for one of the world’s largest pharmaceutical companies

Nordic Nanovector ASA has today published its 2018 Annual Report, including the complete 2018 Annual Accounts with notes

SONIFI Health formally announced the addition of Cheryl Cruver to its executive team in the role of Chief Revenue Officer.

Four student pharmacists from the University of Washington School of Pharmacy took top honors in the Academy of Managed Care Pharmacy Foundation 19th Annual National Student Pharmacist Pharmacy & Therapeutics Competition.

Moderna, Inc. announced that Tal Zaks, M.D., Ph.D., Moderna’s Chief Medical Officer, will participate in a fireside chat at the 18th Annual Needham Healthcare Conference on Wednesday, April 10, 2019 at 11:20 a.m. ET.

Inanovate, Inc., a life science company specializing in the development of blood tests for cancer and autoimmune diseases, has secured an initial closing of $3.1million on a Series C financing round.